CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.20
-2.00 (-3.69%)
Apr 2, 2025, 2:59 PM CST
-10.92%
Market Cap 11.60B
Revenue (ttm) 3.58M
Net Income (ttm) -212.23M
Shares Out 214.01M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153,206
Average Volume 239,318
Open 54.50
Previous Close 54.20
Day's Range 51.60 - 54.50
52-Week Range 49.00 - 72.30
Beta -0.24
RSI 45.15
Earnings Date Mar 21, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.